{"id":"https://openalex.org/W2144547008","doi":"https://doi.org/10.1002/cam4.106","title":"PD \u20101 as a potential target in cancer therapy","display_name":"PD \u20101 as a potential target in cancer therapy","publication_year":2013,"publication_date":"2013-07-21","ids":{"openalex":"https://openalex.org/W2144547008","doi":"https://doi.org/10.1002/cam4.106","mag":"2144547008","pmid":"https://pubmed.ncbi.nlm.nih.gov/24403232","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3892798"},"language":"en","primary_location":{"id":"doi:10.1002/cam4.106","doi":"https://doi.org/10.1002/cam4.106","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.106","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.106","source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.106","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007052233","display_name":"David F. McDermott","orcid":"https://orcid.org/0000-0002-2675-5095","observed_orcids":["https://orcid.org/0000-0002-2675-5095","https://orcid.org/0000-0001-6978-0867"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David F. McDermott","raw_affiliation_strings":["Biologic Therapy Program Beth Israel Deaconess Medical Center Boston Massachusetts","Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologic Therapy Program Beth Israel Deaconess Medical Center Boston Massachusetts","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052526230","display_name":"Michael B. Atkins","orcid":"https://orcid.org/0000-0003-3901-9924","observed_orcids":["https://orcid.org/0000-0003-3901-9924"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Atkins","raw_affiliation_strings":["Georgetown\u2010Lombardi Cancer Center Georgetown University School of Medicine Washington District of Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown\u2010Lombardi Cancer Center Georgetown University School of Medicine Washington District of Columbia","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5007052233"],"corresponding_institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"],"apc_list":{"value":4700,"currency":"USD","value_usd":4700},"apc_paid":{"value":4700,"currency":"USD","value_usd":4700},"fwci":4.4661,"has_fulltext":true,"cited_by_count":418,"citation_normalized_percentile":{"value":0.97081652,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"2","issue":"5","first_page":"662","last_page":"673"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.8320000171661377},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8700000047683716},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.8970000147819519},{"id":"https://openalex.org/keywords/t-cell-dysfunction","display_name":"T cell dysfunction","score":0.6209999918937683},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.800000011920929},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.49300000071525574},{"id":"https://openalex.org/keywords/chronic-inflammation","display_name":"chronic inflammation","score":0.47999998927116394},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.5849999785423279}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6553045511245728},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.6381812691688538},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5914690494537354},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5888972282409668},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5767454504966736},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5700251460075378},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.561924159526825},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5497251152992249},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49238693714141846},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.49120277166366577},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.45942428708076477},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.441205769777298},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4388814866542816},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34681540727615356},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.19897383451461792},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15082064270973206},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007108","descriptor_name":"Immune Tolerance","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1002/cam4.106","doi":"https://doi.org/10.1002/cam4.106","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.106","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.106","source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2881216","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3892798","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3892798","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3892798","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Med","raw_type":"Text"},{"id":"pmid:24403232","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24403232","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer medicine","raw_type":"Journal Article"},{"id":"pmh:oai:dash.harvard.edu:1/11879608","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879608","pdf_url":null,"source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/cam4.106","doi":"https://doi.org/10.1002/cam4.106","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.106","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.106","source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3624732133","display_name":null,"funder_award_id":"P50 CA101942-01","funder_id":"https://openalex.org/F4320310274","funder_display_name":"Dana-Farber/Harvard Cancer Center"},{"id":"https://openalex.org/G4927837899","display_name":"DF/HCC Kidney Cancer SPORE","funder_award_id":"P50CA101942","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8694494015","display_name":null,"funder_award_id":"CA101942","funder_id":"https://openalex.org/F4320310274","funder_display_name":"Dana-Farber/Harvard Cancer Center"}],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320310274","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2144547008.pdf","grobid_xml":"https://content.openalex.org/works/W2144547008.grobid-xml"},"referenced_works_count":66,"referenced_works":["https://openalex.org/W1487731794","https://openalex.org/W1488122804","https://openalex.org/W1497429764","https://openalex.org/W1538902372","https://openalex.org/W1568317937","https://openalex.org/W1661441964","https://openalex.org/W1909069471","https://openalex.org/W1966074771","https://openalex.org/W1973062396","https://openalex.org/W1978857579","https://openalex.org/W1984545852","https://openalex.org/W1986954791","https://openalex.org/W1992597398","https://openalex.org/W2000609012","https://openalex.org/W2004500791","https://openalex.org/W2010121426","https://openalex.org/W2013683525","https://openalex.org/W2015085911","https://openalex.org/W2016732129","https://openalex.org/W2016789384","https://openalex.org/W2017251888","https://openalex.org/W2017950522","https://openalex.org/W2021588881","https://openalex.org/W2029086221","https://openalex.org/W2030259456","https://openalex.org/W2035012596","https://openalex.org/W2039427849","https://openalex.org/W2044835625","https://openalex.org/W2056535502","https://openalex.org/W2057893793","https://openalex.org/W2073382063","https://openalex.org/W2076067786","https://openalex.org/W2095692889","https://openalex.org/W2097855813","https://openalex.org/W2097995306","https://openalex.org/W2101653483","https://openalex.org/W2102575291","https://openalex.org/W2103959341","https://openalex.org/W2107408397","https://openalex.org/W2107564997","https://openalex.org/W2107752337","https://openalex.org/W2112601576","https://openalex.org/W2115525561","https://openalex.org/W2123363005","https://openalex.org/W2129806226","https://openalex.org/W2130066229","https://openalex.org/W2130846254","https://openalex.org/W2131950300","https://openalex.org/W2139591061","https://openalex.org/W2140111836","https://openalex.org/W2141360391","https://openalex.org/W2144256523","https://openalex.org/W2155464214","https://openalex.org/W2157880942","https://openalex.org/W2160834915","https://openalex.org/W2161558877","https://openalex.org/W2162667703","https://openalex.org/W2163804741","https://openalex.org/W2246004191","https://openalex.org/W2249078564","https://openalex.org/W2319499637","https://openalex.org/W2507805159","https://openalex.org/W2559763930","https://openalex.org/W2562841154","https://openalex.org/W2605189400","https://openalex.org/W4230861071"],"related_works":["https://openalex.org/W2036671710","https://openalex.org/W2131620884","https://openalex.org/W2554707488","https://openalex.org/W2945219971","https://openalex.org/W3011541716","https://openalex.org/W2925030036","https://openalex.org/W3098982924","https://openalex.org/W2890158083","https://openalex.org/W3087169700","https://openalex.org/W4353087402"],"abstract_inverted_index":{"Recently,":[0],"an":[1],"improved":[2],"understanding":[3],"of":[4,19,31,60,105,167,197],"the":[5,9,17,26,32,44,177,186,194],"molecular":[6],"mechanisms":[7],"governing":[8],"host":[10],"response":[11],"to":[12,16,149,193],"tumors":[13,66],"has":[14,96],"led":[15],"identification":[18],"checkpoint":[20,35],"signaling":[21],"pathways":[22,36],"involved":[23,50],"in":[24,51,58,102,144,171],"limiting":[25],"anticancer":[27],"immune":[28,41],"response.":[29],"One":[30],"most":[33],"critical":[34],"responsible":[37],"for":[38],"mediating":[39],"tumor-induced":[40],"suppression":[42],"is":[43,74,181],"programmed":[45],"death-1":[46],"(PD-1)":[47],"pathway,":[48],"normally":[49],"promoting":[52],"tolerance":[53],"and":[54,72,90,112,121,138,165],"preventing":[55],"tissue":[56],"damage":[57],"settings":[59],"chronic":[61],"inflammation.":[62],"Many":[63],"human":[64],"solid":[65],"express":[67,88],"PD":[68],"ligand":[69],"1":[70,128],"(PD-L1),":[71],"this":[73],"often":[75],"associated":[76],"with":[77,85],"a":[78],"worse":[79],"prognosis.":[80],"Tumor-infiltrating":[81],"lymphocytes":[82],"from":[83,98],"patients":[84],"cancer":[86],"typically":[87],"PD-1":[89,106,168],"have":[91,125,133,141,150],"impaired":[92],"antitumor":[93],"functionality.":[94],"Proof-of-concept":[95],"come":[97],"several":[99],"preclinical":[100],"studies":[101],"which":[103],"blockade":[104],"or":[107],"PD-L1":[108],"enhanced":[109],"T-cell":[110],"function":[111],"tumor":[113],"cell":[114],"lysis.":[115],"Three":[116],"monoclonal":[117],"antibodies":[118,170],"against":[119,123],"PD-1,":[120],"one":[122],"PD-L1,":[124],"reported":[126],"phase":[127],"data.":[129],"All":[130],"four":[131],"agents":[132,184],"shown":[134],"encouraging":[135,151],"preliminary":[136],"activity,":[137],"those":[139],"that":[140,183],"been":[142],"evaluated":[143],"larger":[145],"patient":[146],"populations":[147],"appear":[148],"safety":[152],"profiles.":[153],"Additional":[154],"data":[155,164],"are":[156],"eagerly":[157],"awaited.":[158],"This":[159],"review":[160],"summarizes":[161],"emerging":[162],"clinical":[163],"potential":[166],"pathway-targeted":[169],"development.":[172],"If":[173],"subsequent":[174],"investigations":[175],"confirm":[176],"initial":[178],"results,":[179],"it":[180],"conceivable":[182],"blocking":[185],"PD-1/PD-L1":[187],"pathway":[188],"will":[189],"prove":[190],"valuable":[191],"additions":[192],"growing":[195],"armamentarium":[196],"targeted":[198],"immunotherapeutic":[199],"agents.":[200]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":26},{"year":2022,"cited_by_count":34},{"year":2021,"cited_by_count":28},{"year":2020,"cited_by_count":68},{"year":2019,"cited_by_count":33},{"year":2018,"cited_by_count":37},{"year":2017,"cited_by_count":42},{"year":2016,"cited_by_count":50},{"year":2015,"cited_by_count":35},{"year":2014,"cited_by_count":24}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}